Skip to content
Home/Companies/Biotech/BOOST Pharma

BOOST Pharma

Biotech·Denmark·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns BOOST Pharma?

BOOST Pharma is a Danish Biotech company, currently owned by Karolinska Development since 2024.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Karolinska Development
Investor
Karolinska Development
Karolinska Development · 2003 · Life Sciences VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Karolinska Development

Other portfolio companies in the same fund.

PharmNovo
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2021
SVF Vaccines
Active
BiotechSweden· 2020
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2011
OssDsign
Active
MedTechSweden· 2011
Biosergen
Active
BiotechSweden· 2004

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns BOOST Pharma?

BOOST Pharma is currently owned by Karolinska Development, through Karolinska Development, since 2024.

When did Karolinska Development acquire BOOST Pharma?

Karolinska Development acquired BOOST Pharma in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue